Vaccines

As tilapia production intensifies, fish health challenges are evolving — but so is fish health management. Find out how vaccines and other techniques are helping Brazil’s tilapia producers stay competitive and sustainabl…

Among the most economically important farmed fish, production methods, levels of technological development and the types of fish health and well-being issues faced can vary widely — and those in the industry that make a …

Six aquaculture-related projects in Bangladesh, Ghana, Malawi and Zambia have been awarded a share of $1.15 million in grant funding by the Fish Innovation Lab at Mississippi State University (MSU).

Andreas von Scholten, CEO of Barramundi Group, talks about the future of aquaculture, the importance of vaccines and building the company’s ground-breaking operations in Brunei.

ICAR-CIBA has launched a recombinant vaccine against viral nervous necrosis (VNN), in a milestone for aquaculture vaccine development in India.

Eight urban aquaculture projects are among the 12 projects chosen to receive a share of $23 million in funding from the Singapore Food Agency (SFA).

Researchers are optimistic about the possibility of developing an oral vaccine against francisellosis in tilapia, following promising trials in Thailand.

New research from the University of Aberdeen could allow the development of drugs and vaccines to treat a disease that is rapidly emerging in aquaculture as a result of climate change.

The provision of safe and effective vaccination programmes is one of the key tools to ensure the sustainable development of the aquaculture sector and therefore help meet growing global protein demands.

An oral vaccine that protects tilapia from Streptococcusinfection is due to be trialled on farms before the end of the year.

Plans to develop a new range of novel algae-based vaccines that can be delivered orally to animals including farmed fish and shrimp have been given a boost by the completion of a new partnership.

Investment firms in the aquaculture sector are looking at the seafood industry’s broader canvas for profits instead of solely focusing on biomass.

Vaccines based on synthetic DNA rather than whole viruses could offer the aquaculture sector a novel and relatively economical means for tackling a range of diseases across species.

A new aquaculture vaccine development company has been launched by Touchlight Genetics and Stonehaven Incubate.

Benchmark is selling its vaccine manufacturing facility as part of a £100 million UK government project to mass produce a vaccine against Covid-19.

A new line of syringes from Socorex has been launched for a variety of sectors including aquaculture.

Trials of a new vaccine against infectious pancreatic necrosis virus (IPNV) in rainbow trout have shown promising results.

Norwegian salmon were given 397 doses of vaccines in 2019 - 28 million more than the previous year.

Plans to develop and launch a “transformational” fish vaccinating robot by the end of next year have been boosted by a £250,000 grant.

A polyvalent vaccine can help to protect both tilapia broodstock and their offspring from the effects of Streptococcus agalactiae, according to a new study.